WO2003097033A3 - Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations - Google Patents

Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations Download PDF

Info

Publication number
WO2003097033A3
WO2003097033A3 PCT/FR2003/001544 FR0301544W WO03097033A3 WO 2003097033 A3 WO2003097033 A3 WO 2003097033A3 FR 0301544 W FR0301544 W FR 0301544W WO 03097033 A3 WO03097033 A3 WO 03097033A3
Authority
WO
WIPO (PCT)
Prior art keywords
fatty acids
neutracetical
pharmaceutical compositions
acid
novel
Prior art date
Application number
PCT/FR2003/001544
Other languages
English (en)
Other versions
WO2003097033A2 (fr
Inventor
Ludovic Predal
Original Assignee
Synergia Holding
Ludovic Predal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergia Holding, Ludovic Predal filed Critical Synergia Holding
Priority to AU2003258772A priority Critical patent/AU2003258772A1/en
Priority to EP03752849A priority patent/EP1555894A2/fr
Priority to US10/554,155 priority patent/US7740885B2/en
Publication of WO2003097033A2 publication Critical patent/WO2003097033A2/fr
Publication of WO2003097033A3 publication Critical patent/WO2003097033A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention se rapporte au domaine de la chimie organique et plus particulièrement au domaine des acides gras polyinsaturés. L'invention se rapporte spécifiquement à des compositions nutraceutiques ou pharmaceutiques riches en acides gras non saturés caractérisées en ce qu'elles renferment de l'acide α-linolénique sous forme libre ou combinée, associé à des acides gras à cinq double liaisons et à des acides gras à six double liaisons, en mélange avec un excipient ou un véhicule approprié pour l'administration par voie digestive. Utilisation pour la prévention ou le traitement des maladies cardio-vasculaires chez l'homme ou l'animal à une dose s'échelonnant de 800 à 1.000 mg d'acide α-linolénique, de 80 à 120 mg d'acide eicosapentaénoïque et de 250 à 300 mg d'acide docosahexanénoïque.
PCT/FR2003/001544 2002-05-22 2003-05-22 Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations WO2003097033A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2003258772A AU2003258772A1 (en) 2002-05-22 2003-05-22 Novel neutracetical and pharmaceutical compositions and their uses
EP03752849A EP1555894A2 (fr) 2002-05-22 2003-05-22 Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations
US10/554,155 US7740885B2 (en) 2002-05-22 2003-05-22 Nutraceutical and pharmaceutical compositions and their uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0206205A FR2839887A1 (fr) 2002-05-22 2002-05-22 Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
FR02/06205 2002-05-22

Publications (2)

Publication Number Publication Date
WO2003097033A2 WO2003097033A2 (fr) 2003-11-27
WO2003097033A3 true WO2003097033A3 (fr) 2004-03-11

Family

ID=29414968

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/001544 WO2003097033A2 (fr) 2002-05-22 2003-05-22 Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations

Country Status (5)

Country Link
US (1) US7740885B2 (fr)
EP (1) EP1555894A2 (fr)
AU (1) AU2003258772A1 (fr)
FR (1) FR2839887A1 (fr)
WO (1) WO2003097033A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865353B1 (fr) * 2004-01-23 2009-01-09 Synergia Holding Nouveaux complements dietetiques ou alimentaires a base d'acide gras insature et leurs utilisation
NZ539698A (en) * 2005-04-29 2007-12-21 Vital Food Processors Ltd Kiwifruit seed oil extraction method and product
CA2567879C (fr) * 2006-11-14 2013-03-26 Thomas Greither Compositions d'huile alimentaire nutritive et methodes pour les produire
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266323A1 (fr) * 1986-09-29 1988-05-04 KabiVitrum AB Tablette contenante de l'acide linoléique, de l'acide eicosapentaénoique et/ou de l'acide docosahexaénoique, et procédé pour sa préparation
WO1993019624A1 (fr) * 1992-03-31 1993-10-14 Abbott Laboratories Produit nutritif pour patients souffrant d'une affection pulmonaire
JPH06169735A (ja) * 1992-12-10 1994-06-21 Nippon Oil & Fats Co Ltd 栄養飲料組成物
EP0611568A1 (fr) * 1993-02-13 1994-08-24 Fresenius AG Préparation pour alimentation entérale
JPH06237734A (ja) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
FR2721517A1 (fr) * 1994-06-24 1995-12-29 Biovaleur Sa Composition pharmaceutique utilisée en tant que complément alimentaire.
WO2001078530A2 (fr) * 2000-04-13 2001-10-25 Abbott Laboratories Preparations pour nourrissons contenant des acides gras poly-insatures a longue chaine et leurs utilisations
EP1155620A1 (fr) * 2000-05-18 2001-11-21 SportsCom Danmark ApS Composition nutritive comme suppléments diététiques
EP1181870A1 (fr) * 2000-08-22 2002-02-27 Belovo Eggs & Egg Products Emulsion de lipides constituant une source alimentaire de vitamine F plus equilibrée

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637910B1 (fr) 1988-10-18 1993-04-30 Azar Roger Nouveau procede d'obtention d'huile de pepins de cassis enrichie
JPH0748992B2 (ja) * 1990-04-16 1995-05-31 日本油脂株式会社 血栓防止用粉末組成物
US5223282A (en) * 1991-02-01 1993-06-29 Wm. Wrigley Jr. Company Methods of producing chewing gum using molten sorbitol and gum produced thereby
KR930006432B1 (ko) * 1991-04-10 1993-07-16 주식회사 우방랜드 아이코사펜타노산 및 α-리놀렌산을 함유하는 여드름 치료제 조성물
GB9217781D0 (en) 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
FR2731015B1 (fr) 1995-02-24 1997-05-30 Sci Sartone Procede d'enrichissement enzymatique d'huiles d'origine marine et les triglycerides d'acides gras polyinsatures ainsi obtenus
US6630192B2 (en) * 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
EP1827123B1 (fr) * 2004-11-04 2015-07-22 Monsanto Technology, LLC Compositions d'huile a concentration elevee en acides gras polyinsatures

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266323A1 (fr) * 1986-09-29 1988-05-04 KabiVitrum AB Tablette contenante de l'acide linoléique, de l'acide eicosapentaénoique et/ou de l'acide docosahexaénoique, et procédé pour sa préparation
JPH06237734A (ja) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
WO1993019624A1 (fr) * 1992-03-31 1993-10-14 Abbott Laboratories Produit nutritif pour patients souffrant d'une affection pulmonaire
JPH06169735A (ja) * 1992-12-10 1994-06-21 Nippon Oil & Fats Co Ltd 栄養飲料組成物
EP0611568A1 (fr) * 1993-02-13 1994-08-24 Fresenius AG Préparation pour alimentation entérale
FR2721517A1 (fr) * 1994-06-24 1995-12-29 Biovaleur Sa Composition pharmaceutique utilisée en tant que complément alimentaire.
WO2001078530A2 (fr) * 2000-04-13 2001-10-25 Abbott Laboratories Preparations pour nourrissons contenant des acides gras poly-insatures a longue chaine et leurs utilisations
EP1155620A1 (fr) * 2000-05-18 2001-11-21 SportsCom Danmark ApS Composition nutritive comme suppléments diététiques
EP1181870A1 (fr) * 2000-08-22 2002-02-27 Belovo Eggs & Egg Products Emulsion de lipides constituant une source alimentaire de vitamine F plus equilibrée

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199429, Derwent World Patents Index; Class B05, AN 1994-237558, XP002259378 *
DATABASE WPI Section Ch Week 199439, Derwent World Patents Index; Class B05, AN 1994-312783, XP002259377 *
TAGUCHI K ET AL: "Preservability and utilization of powdered.Na-linolenic acid with egg white.", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY 1992 DEP. OF HOME SCI., KOKA WOMEN'S JUNIOR COLL., NISHIKYOGOKU, UKYO-KU, KYOTO 615, JAPAN, vol. 56, no. 4, pages 672 - 673, XP008023776 *

Also Published As

Publication number Publication date
US7740885B2 (en) 2010-06-22
FR2839887A1 (fr) 2003-11-28
AU2003258772A8 (en) 2003-12-02
AU2003258772A1 (en) 2003-12-02
EP1555894A2 (fr) 2005-07-27
WO2003097033A2 (fr) 2003-11-27
US20070128292A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
JP2020011958A (ja) ω３脂肪酸の自己乳化組成物
WO2000040705A3 (fr) Gene desaturase humain et ses utilisations
HUP0301107A2 (hu) Zsírsavak gyógyhatású kombinációi és alkalmazásuk
WO2002090493A3 (fr) Genes de delta 4-desaturase et leurs applications
DE60000133T2 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
WO1999047135A8 (fr) Compositions a base d'acides linoleiques conjugues
WO2000051576A3 (fr) Nouveaux produits pharmaceutiques, supplements alimentaires et compositions cosmetiques, et utilisation de certains melanges pour preparer un medicament ou un supplement alimentaire afin de traiter ou de prevenir une inflammation, des reactions d'hypersensibilite ou une douleur
WO2009091538A3 (fr) Composition pharmaceutique et méthode permettant de traiter l'hypertriglycéridemie et l'hypercholestérolémie chez des mammifères
WO2002043659A3 (fr) Composition contenant des statines et du calcium destinee a ameliorer la sante cardiovasculaire
AR020717A1 (es) Proteinas terapeuticamente activas en plantas.
WO2002008401A3 (fr) Genes d'elongase et leurs utilisations
ATE427925T1 (de) Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
DE60138468D1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
RU2008103281A (ru) Способы и композиции для профилактики и лечения воспалительного заболевания
DK1121115T4 (da) PUFA-tilskud
AR029615A1 (es) Una formulacion farmaceutica para la administracion oral
ATE456645T1 (de) Funktionelle acylglyceride
CA2578881A1 (fr) Compositions de vitamine d et methode d'administration a un etre humain
ATE413865T1 (de) Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür
DE602006000819D1 (de) Dipyridamol enthaltende Zusammensetzungen mit verlängerter Freisetzung und Verfahren zu deren Herstellung
CA2535013A1 (fr) Formulation de dosage de solides de sels d'acides gras destinee a des agents therapeutiques
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
WO2006109194A3 (fr) Composes de chrome et d'acides gras et leurs procedes de fabrication et d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AU BA BR BY BZ CA CN CO CR CU DM DZ EC HR ID IL IN IS JP KR LK LR LT MA MG MX NO NZ OM PH PT RU TN UA US VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003752849

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003752849

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007128292

Country of ref document: US

Ref document number: 10554155

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 10554155

Country of ref document: US